Appendix 4C - Quarterly
Filed with ASX ·
6ix hasn’t read this filing yet.
Neurizon Therapeutics Limited on 6ix
Earlier from Neurizon Therapeutics
- Human Cancer Trial Advancing To Second Patient
- Clinical Trial in Dogs is now open for accrual
- Appendix 4C Quarterly & Company Update
- Strategy for Phase II Clinical Trial of Monepantel
- Appendix 4D & Half Yearly Report and Accounts
Later from Neurizon Therapeutics
- Appendix 4D and Financial Report Dec 2012
- Appendix 4D / Half Year Financial Report
- Clarification on Record Date for SPP
- PharmAust to acquire rights to 3 oncology product platforms
- Placement & Offer to Purchase Pela Resources
Follow Neurizon Therapeutics into a list and get an email when it puts out news.
Follow Neurizon Therapeutics